<?xml version='1.0' encoding='UTF-8'?>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">3010260</PMID>
<DateCreated>
<Year>1986</Year>
<Month>06</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>1986</Year>
<Month>06</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0032-3756</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>41</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1986</Year>
<Month>Jan</Month>
<Day>13</Day>
</PubDate>
</JournalIssue>
<Title>Polski tygodnik lekarski (Warsaw, Poland : 1960)</Title>
<ISOAbbreviation>Pol Tyg Lek</ISOAbbreviation>
</Journal>
<ArticleTitle>[Effect of naloxone on parathyroid hormone and calcitonin secretion and 25-hydroxyvitamin D levels in patients with acute renal failure].</ArticleTitle>
<Pagination>
<MedlinePgn>38-41</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Grzeszczak</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kokot</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Duława</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>pol</Language>
<PublicationTypeList>
<PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<VernacularTitle>Wpływ naloksonu na wydzielanie parathormonu (PTH) i kalcytoniny oraz stezenie 25-hydroksy-witaminy D u chorych na ostra niewydolność nerek.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>POLAND</Country>
<MedlineTA>Pol Tyg Lek</MedlineTA>
<NlmUniqueID>9705468</NlmUniqueID>
<ISSNLinking>0032-3756</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011957">Receptors, Opioid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>36B82AMQ7N</RegistryNumber>
<NameOfSubstance UI="D009270">Naloxone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-12-9</RegistryNumber>
<NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>P6YZ13C99Q</RegistryNumber>
<NameOfSubstance UI="D002112">Calcifediol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058186">Acute Kidney Injury</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002112">Calcifediol</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002116">Calcitonin</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000557">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009270">Naloxone</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010280">Parathyroid Glands</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010281">Parathyroid Hormone</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000557">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011957">Receptors, Opioid</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013960">Thyroid Function Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013961">Thyroid Gland</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
